Business Context and Reporting Period
Company: SANUWAVE Health, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 4, 2010
Event: Entry into Material Definitive Agreements involving the issuance of convertible promissory notes.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, or general liquidity metrics. It specifically discloses the creation of a direct financial obligation:
- Total Principal Amount: $200,000 (Two notes of $100,000 each).
- Interest Rate: 5% per annum (increases to 10% per annum if not paid within three business days of maturity).
- Maturity Date: 90 days from issuance (approximately September 2, 2010).
- Security Status: Unsecured.
- Collection Costs: Company agreed to pay 15% of principal and interest as attorneys' fees if collection is required.
Material Changes and Terms
The Company entered into agreements with Durk V. Irwin and Todd R. Pedersen. Key terms include:
- Conversion Trigger: Notes convert upon a "Qualified Financing" (private placement of at least $3,000,000) or if not paid by maturity.
- Qualified Financing Conversion: Converts to Common Stock at the financing price, plus a warrant for the same number of shares, plus any other securities issued in the financing.
- Default Conversion (No Financing): If not paid or converted by maturity, the holder receives a warrant to purchase Common Stock at $4.00 per share. The number of shares is calculated by dividing the total principal and interest by 20.
Outlook, Risks, and Contingencies
Management Commentary: The filing contains no forward-looking guidance or management commentary beyond the terms of the notes.
Risks and Contingencies:
- Dilution Risk: Significant potential dilution exists if a Qualified Financing occurs, as holders receive stock, warrants, and other securities.
- Liquidity Risk: The Company must raise $3,000,000 to trigger favorable conversion terms or repay $200,000 plus interest by the maturity date.
- Penalty Interest: Failure to pay within three business days of maturity triggers a penalty interest rate of 10% per annum.
Investor Verification Checklist
- Verify the Company's current cash position and ability to repay $200,000 by the maturity date.
- Confirm the status of any ongoing efforts to secure a $3,000,000 Qualified Financing.
- Assess the potential dilution impact on existing shareholders if the notes convert into stock and warrants.
- Review the Company's history of meeting debt obligations to evaluate the risk of penalty interest and legal fees.